Hims & Hers Health (HIMS) Cash & Equivalents (2019 - 2026)

Hims & Hers Health has disclosed Cash & Equivalents across 8 years of filings, most recently posting $609.8 million for Q2 2026.

• In Q2 2026, Cash & Equivalents fell 45.77% year-over-year to $609.8 million; the TTM figure through Jun 2026 stood at $609.8 million (down 45.77% YoY), while the FY2025 annual figure was $228.6 million, up 3.64% from the prior year.
• Cash & Equivalents came in at $609.8 million for Q2 2026 at Hims & Hers Health, up from $222.3 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $1.1 billion in Q2 2025 to a low of $46.8 million in Q4 2022.
• Average Cash & Equivalents over 5 years is $216.8 million, with a median of $117.3 million recorded in 2024.
• Year-over-year, Cash & Equivalents slumped 48.64% in 2022 and soared 769.78% in 2025.
• Over 5 years, Cash & Equivalents stood at $46.8 million in 2022, then jumped by 106.67% to $96.7 million in 2023, then jumped by 128.2% to $220.6 million in 2024, then grew by 3.64% to $228.6 million in 2025, then surged by 166.74% to $609.8 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $609.8 million in Q2 2026, $222.3 million in Q1 2026, and $228.6 million in Q4 2025.